Publications Office of the EU
Poland-Warsaw: Laboratory reagents - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Poland-Warsaw: Laboratory reagents

Overview
  • Awarded
    12/10/2022
  • Today
    18/09/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Mazowiecki Szpital Bródnowski Sp. z o.o.
Place of performance
NUTS code: PL Polska
Location of buyer
NUTS code: PL Polska
Business sector (Main CPV)
33696500 Laboratory reagents
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
46,481.00 PLN
Procedure details
Tender reference number
MSB/60/08/2022
Description

Dostawa zestawu odczynników i przeciwciał di diagnostyki immunohistochemicznej oraz markera dla Zakładu Patomorfologii Mazowieckiego Szpitala Bródnowskiego Sp. z o.o.

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
PL Polska
CPV code

33696500 - Laboratory reagents

Award method
Lowest price
Estimated value
Not available
Final contracted value
46,481.00 PLN
Award of contract
Official name: Perlan Technologies Polska Sp. z o.o.
Postal address: ul. Puławska 303
Town: Warszawa
Postal code: 02-785
Country: POL
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.